BEGIN:VCALENDAR
VERSION:2.0
METHOD:PUBLISH
CALSCALE:GREGORIAN
PRODID:-//WordPress - MECv6.5.5//EN
X-ORIGINAL-URL:https://fokuspatient.se/
X-WR-CALNAME:Fokus Patient
X-WR-CALDESC:- Alltid patienten i fokus
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-PUBLISHED-TTL:PT1H
X-MS-OLK-FORCEINSPECTOROPEN:TRUE
BEGIN:VEVENT
CLASS:PUBLIC
DTSTART;TZID=Europe/Stockholm:20230220T100000
DTEND;TZID=Europe/Stockholm:20230220T130000
DTSTAMP:20250114T131500
UID:MEC-b5bd9ec2c8ff3cb0c9f606c1a59ec4b9@fokuspatient.se
CREATED:20250114
LAST-MODIFIED:20250114
PRIORITY:5
TRANSP:OPAQUE
SUMMARY:Seminarium – Sällsynta cancerdiagnoser
DESCRIPTION:Program FOKUS Rare Cancers Seminar\nFebruary 2023 at 10.00-12.45\nDigital seminar – in English\nKl.10.00 Welcome by Penilla Gunther, Founder of FOKUS Patient® and Member of Cancer Mission Board, for implementing Europe’s Beating Cancer Plan.\nKl.10.05 Detection of cancer through new diagnostics.\n Genetical testing is performed for a handful gene changes indicating that tumors can answer targeted treatment for these changes. GMS – Genomic Medicine Sweden aiming to develop and introduce in clinical routines, a targeted diagnostics for mutations in about 500 genes relevant to the development of the cancer and choice of treatment.\nRichard Rosenquist Brandell, Chair GMS Board and Professor of Clinical Genetics, Karolinska University Hospital\nKl.10.25 Rare Cancers’ Challenges and Patients’ Needs: The Views of European Patient Advocates\nAriane Weinman, Public Affairs Senior Manager, the European organization of Rare Diseases, EURORDIS\nRepr The National Patient Organization for Rare Diseases in Sweden TBC\nKl.10.45 Rare Cancers in Europe – how does the research and development looks like? Ivana Cattaneo, Member of Steering Committee, Rare Cancers Europe & Executive Director Oncology Policy & Healthcare Systems, Novartis\nKl.11.05 Examples of cancer diagnoses in Sweden and the patient organization’s view on research and future for new treatments\nSarcoma\nMagnus Carlsson, President, The Swedish Patient Association for Sarcoma\nRare Blood Cancer\nLise-lott Eriksson, President, The Swedish Blood Cancer Patient Association and President of Myeloma Patient Europe\nPancreas and other cancers\nAnders Bovin, Member of Board, The Swedish Cancer Patient Organization PALEMA\nKl.11.55 The knowledge of Rare Cancer and hereditary cancer\nOnco-genetic clinics investigate hereditary cancer and work has started to establish for a centre for personcentered cancer prevention with focus on families with hereditary cancer risks which will increase information and knowledge.\nSvetlana Bajalica Lagercrantz, Associate Professor, National Co-ordinator European Network for Hereditary Cancer Risk Syndromes (ERN GENTURIS), Process leader at Regional Cancer Centre (RCC) Stockholm Gotland for Rare Cancer Risk Syndromes\nKl.12.15 Discussion with speakers and participants\nKl.12.45 Avslutning\nANMÄLAN TILL\npenilla@fokuspatient.se ( mailto:penilla@fokuspatient.se ) senast den 18/2 för länk till seminariet\nVARMT VÄLKOMMEN!\n
URL:https://fokuspatient.se/events/seminarium-sallsynta-cancerdiagnoser-2/
ORGANIZER;CN=FOKUS Patient:MAILTO:info@fokuspatient.se
LOCATION:Digitalt möte
ATTACH;FMTTYPE=image/png:https://fokuspatient.se/wp-content/uploads/2025/01/Fokus-Patient-klar-1.png
END:VEVENT
END:VCALENDAR